Skip to content
FindTrial
Search trials
Search trials by condition, treatment, sponsor...
Sign In
Subunit influenza vaccine
BIOLOGICAL
2 trials
Sponsors
Novartis
, Insel Gruppe AG, University Hospital Bern
Conditions
Immunosuppression
Influenza Infection
Phase 1
Safety, Tolerability, Immunogenicity And CPG Dosage Finding Study of Novartis CpG Adjuvanted Flu Vaccine
Completed
NCT00559975
Novartis
Influenza Infection
Start: 2007-10-31
End: 2008-05-31
Target: 60
Updated: 2009-11-05
Phase 4
Influenza Vaccination in Immunocompromized Patients
Completed
NCT00783380
Insel Gruppe AG, University Hospital Bern
Immunosuppression
Start: 2005-10-31
End: 2008-03-31
Updated: 2008-11-03
Related Papers
Randomized, double-blind comparative trial of subunit and virosomal influenza vaccines for immunocompromised patients.
2009-05-01
64 citations